Overexpression of tumor necrosis factor causes bilateral sacroiliitis
Open Access
- 5 March 2004
- journal article
- concise communications
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (3), 1001-1005
- https://doi.org/10.1002/art.20194
Abstract
No abstract availableFunding Information
- Austrian Science Fund
- Austrian National Bank (8715)
- Center of Molecular Medicine (CEMM) of the Austrian Federal Ministry for Education, Science and Culture
- City of Vienna
This publication has 9 references indexed in Scilit:
- Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor αNew England Journal of Medicine, 2002
- Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trialThe Lancet, 2002
- Infliximab treatment of severe ankylosing spondylitis: One-year followupArthritis & Rheumatism, 2001
- Role of the Mouse ank Gene in Control of Tissue Calcification and ArthritisScience, 2000
- Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factorArthritis & Rheumatism, 2000
- Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.The EMBO Journal, 1991
- Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: An animal model of HLA-B27-associated human disordersCell, 1990
- Proteoglycan‐induced arthritis in balb/c miceArthritis & Rheumatism, 1987